Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

DARVON-N

PROPOXYPHENE NAPSYLATE

Standard Dose
50MG/5ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview DARVON-N is listed in Drugs@FDA under application 016861 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient PROPOXYPHENE NAPSYLATE Form and strength SUSPENSION;ORAL - 50MG/5ML Sponsor AAIPHARMA LLC Submission history Latest submission status date: 1994-08-23 00:00:00.

Structured Monograph

Clinical summary

Approval overview DARVON-N is listed in Drugs@FDA under application 016861 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient PROPOXYPHENE NAPSYLATE Form and strength SUSPENSION;ORAL - 50MG/5ML Sponsor AAIPHARMA LLC Submission history Latest submission status date: 1994-08-23 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.